Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease (Clinical and Experimental Nephrology, (2023), 27, 10, (809-818), 10.1007/s10157-023-02372-8)

Hiroshi Kataoka; Yosuke Shimada; Tomonori Kimura; Saori Nishio; Shinya Nakatani; Toshio Mochizuki; Ken Tsuchiya; Junichi Hoshino; Fumihiko Hattanda; Haruna Kawano; Kazushige Hanaoka; Sumi Hidaka; Daisuke Ichikawa; Eiji Ishikawa; Kiyotaka Uchiyama; Hiroki Hayashi; Shiho Makabe; Shun Manabe; Michihiro Mitobe; Akinari Sekine; Tatsuya Suwabe; Hirayasu Kai; Mahiro Kurashige; Koichi Seta; Keiji Shimazu; Tomofumi Moriyama; Mai Sato; Tadashi Otsuka; Kan Katayama; Wataru Shimabukuro; Takuya Fujimaru; Kenichiro Miura; Koichi Nakanishi; Shigeo Horie; Kengo Furuichi; Hirokazu Okada; Ichiei Narita; Satoru Muto

doi:10.1007/s10157-023-02426-x

Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease (Clinical and Experimental Nephrology, (2023), 27, 10, (809-818), 10.1007/s10157-023-02372-8)

Hiroshi Kataoka, Yosuke Shimada, Tomonori Kimura, Saori Nishio, Shinya Nakatani, Toshio Mochizuki, Ken Tsuchiya, Junichi Hoshino, Fumihiko Hattanda, Haruna Kawano, Kazushige Hanaoka, Sumi Hidaka, Daisuke Ichikawa, Eiji Ishikawa, Kiyotaka Uchiyama, Hiroki Hayashi, Shiho Makabe, Shun Manabe, Michihiro Mitobe, Akinari SekineTatsuya Suwabe, Hirayasu Kai, Mahiro Kurashige, Koichi Seta, Keiji Shimazu, Tomofumi Moriyama, Mai Sato, Tadashi Otsuka, Kan Katayama, Wataru Shimabukuro, Takuya Fujimaru, Kenichiro Miura, Koichi Nakanishi, Shigeo Horie, Kengo Furuichi, Hirokazu Okada, Ichiei Narita, Satoru Muto

医学部・腎臓内科学

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

抄録

In the original publication, the third author Tomonori Kimura was inadvertently missed to include in the author group. The author's affiliation details are as follows: Tomonori Kimura Reverse Translational Research Project, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan The original article has been corrected.

本文言語	英語
ページ（範囲）	82-83
ページ数	2
ジャーナル	Clinical and Experimental Nephrology
巻	28
号	1
DOI	https://doi.org/10.1007/s10157-023-02426-x
出版ステータス	出版済み - 01-2024

All Science Journal Classification (ASJC) codes

生理学
腎臓病学
生理学（医学）

文献へのアクセス

10.1007/s10157-023-02426-x

他のファイルとリンク

フィンガープリント

「Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease (Clinical and Experimental Nephrology, (2023), 27, 10, (809-818), 10.1007/s10157-023-02372-8)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Kataoka, H., Shimada, Y., Kimura, T., Nishio, S., Nakatani, S., Mochizuki, T., Tsuchiya, K., Hoshino, J., Hattanda, F., Kawano, H., Hanaoka, K., Hidaka, S., Ichikawa, D., Ishikawa, E., Uchiyama, K., Hayashi, H., Makabe, S., Manabe, S., Mitobe, M., ... Muto, S. (2024). Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease (Clinical and Experimental Nephrology, (2023), 27, 10, (809-818), 10.1007/s10157-023-02372-8). Clinical and Experimental Nephrology, 28(1), 82-83. https://doi.org/10.1007/s10157-023-02426-x

Kataoka, Hiroshi ; Shimada, Yosuke ; Kimura, Tomonori その他. / Correction to : Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease (Clinical and Experimental Nephrology, (2023), 27, 10, (809-818), 10.1007/s10157-023-02372-8). In: Clinical and Experimental Nephrology. 2024 ; Vol. 28, No. 1. pp. 82-83.

@article{392e7eb08daa4eab95bbfc1105e6e6ea,

title = "Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease (Clinical and Experimental Nephrology, (2023), 27, 10, (809-818), 10.1007/s10157-023-02372-8)",

abstract = "In the original publication, the third author Tomonori Kimura was inadvertently missed to include in the author group. The author's affiliation details are as follows: Tomonori Kimura Reverse Translational Research Project, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan The original article has been corrected.",

author = "Hiroshi Kataoka and Yosuke Shimada and Tomonori Kimura and Saori Nishio and Shinya Nakatani and Toshio Mochizuki and Ken Tsuchiya and Junichi Hoshino and Fumihiko Hattanda and Haruna Kawano and Kazushige Hanaoka and Sumi Hidaka and Daisuke Ichikawa and Eiji Ishikawa and Kiyotaka Uchiyama and Hiroki Hayashi and Shiho Makabe and Shun Manabe and Michihiro Mitobe and Akinari Sekine and Tatsuya Suwabe and Hirayasu Kai and Mahiro Kurashige and Koichi Seta and Keiji Shimazu and Tomofumi Moriyama and Mai Sato and Tadashi Otsuka and Kan Katayama and Wataru Shimabukuro and Takuya Fujimaru and Kenichiro Miura and Koichi Nakanishi and Shigeo Horie and Kengo Furuichi and Hirokazu Okada and Ichiei Narita and Satoru Muto",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Japanese Society of Nephrology.",

year = "2024",

month = jan,

doi = "10.1007/s10157-023-02426-x",

language = "English",

volume = "28",

pages = "82--83",

journal = "Clinical and Experimental Nephrology",

issn = "1342-1751",

publisher = "Springer",

number = "1",

}

Kataoka, H, Shimada, Y, Kimura, T, Nishio, S, Nakatani, S, Mochizuki, T, Tsuchiya, K, Hoshino, J, Hattanda, F, Kawano, H, Hanaoka, K, Hidaka, S, Ichikawa, D, Ishikawa, E, Uchiyama, K, Hayashi, H, Makabe, S, Manabe, S, Mitobe, M, Sekine, A, Suwabe, T, Kai, H, Kurashige, M, Seta, K, Shimazu, K, Moriyama, T, Sato, M, Otsuka, T, Katayama, K, Shimabukuro, W, Fujimaru, T, Miura, K, Nakanishi, K, Horie, S, Furuichi, K, Okada, H, Narita, I & Muto, S 2024, 'Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease (Clinical and Experimental Nephrology, (2023), 27, 10, (809-818), 10.1007/s10157-023-02372-8)', Clinical and Experimental Nephrology, vol. 28, no. 1, pp. 82-83. https://doi.org/10.1007/s10157-023-02426-x

Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease (Clinical and Experimental Nephrology, (2023), 27, 10, (809-818), 10.1007/s10157-023-02372-8). / Kataoka, Hiroshi; Shimada, Yosuke; Kimura, Tomonori その他.
In: Clinical and Experimental Nephrology, Vol. 28, No. 1, 01.2024, p. 82-83.

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

TY - JOUR

T1 - Correction to

T2 - Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease (Clinical and Experimental Nephrology, (2023), 27, 10, (809-818), 10.1007/s10157-023-02372-8)

AU - Kataoka, Hiroshi

AU - Shimada, Yosuke

AU - Kimura, Tomonori

AU - Nishio, Saori

AU - Nakatani, Shinya

AU - Mochizuki, Toshio

AU - Tsuchiya, Ken

AU - Hoshino, Junichi

AU - Hattanda, Fumihiko

AU - Kawano, Haruna

AU - Hanaoka, Kazushige

AU - Hidaka, Sumi

AU - Ichikawa, Daisuke

AU - Ishikawa, Eiji

AU - Uchiyama, Kiyotaka

AU - Hayashi, Hiroki

AU - Makabe, Shiho

AU - Manabe, Shun

AU - Mitobe, Michihiro

AU - Sekine, Akinari

AU - Suwabe, Tatsuya

AU - Kai, Hirayasu

AU - Kurashige, Mahiro

AU - Seta, Koichi

AU - Shimazu, Keiji

AU - Moriyama, Tomofumi

AU - Sato, Mai

AU - Otsuka, Tadashi

AU - Katayama, Kan

AU - Shimabukuro, Wataru

AU - Fujimaru, Takuya

AU - Miura, Kenichiro

AU - Nakanishi, Koichi

AU - Horie, Shigeo

AU - Furuichi, Kengo

AU - Okada, Hirokazu

AU - Narita, Ichiei

AU - Muto, Satoru

PY - 2024/1

Y1 - 2024/1

N2 - In the original publication, the third author Tomonori Kimura was inadvertently missed to include in the author group. The author's affiliation details are as follows: Tomonori Kimura Reverse Translational Research Project, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan The original article has been corrected.

AB - In the original publication, the third author Tomonori Kimura was inadvertently missed to include in the author group. The author's affiliation details are as follows: Tomonori Kimura Reverse Translational Research Project, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85175850583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85175850583&partnerID=8YFLogxK

U2 - 10.1007/s10157-023-02426-x

DO - 10.1007/s10157-023-02426-x

M3 - Comment/debate

C2 - 37924433

AN - SCOPUS:85175850583

SN - 1342-1751

VL - 28

SP - 82

EP - 83

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

IS - 1

ER -

Kataoka H, Shimada Y, Kimura T, Nishio S, Nakatani S, Mochizuki T その他. Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease (Clinical and Experimental Nephrology, (2023), 27, 10, (809-818), 10.1007/s10157-023-02372-8). Clinical and Experimental Nephrology. 2024 1月;28(1):82-83. doi: 10.1007/s10157-023-02426-x